Monday, October 24, 2016 2:00:02 PM
SINCE THE LAST RUN UP NOTHING HAS CHANGED WITH THIS COMPANY. FOR YOUR BENEFIT CONSIDER THIS BEFORE LOSING YOUR MONEY !!IMPORTANT MESSAGE...PUMP ABORTED BUYER BE WARE !!!!!! READ THIS ..... COMPANY IN WORST POSITION TODAY!!! DON'T BUY ONE SHARE OF THIS MAKE BELIEVE COMPANY !!!!
Sunshine Biopharma, Inc. (OTCMKTS:SBFM) Turns Bright Red
by Dragni Dragnev
January 12, 2016
0 0 1 Comments
As usual when dealing with an OTC Markets penny stock, it is impossible to be absolutely certain where SBFM will head. However, there are some clues that investors should definitely consider.
First off, the surge that has taken the ticker from $0.0025 to $0.03 was kicked off by the announcement that the company has securing all remaining worldwide patents for its Adva-27a compound. That is certainly good news, but is it really good enough to justify the ticker's 1000% jump that ensued in the two weeks that followed?
After all, we're still talking about a company whose financials looked like this at the end of Q3 2015:
cash - $125 thousand
total assets - $136 thousand
total current liabilities - $469 thousand
NO REVENUES
net loss - $202 thousand
And while on the subject of horrifying numbers – one would be remiss not to mention the hideous levels of dilution that the company has put investors through over the course of 2015. Suffice it to say that as of November 10, 2014 there were 69 million shares of SBFM common stock outstanding. As of November 4, 2015 that number had grown all the way up to 138 million.
And if you think that's bad enough, consider the fact that most of those shares have come into existence at a significant discount. Furthermore, it's unlikely that all of SBFM's discounted debt has been converted into shares either.
Add the fact that SBFM paid for securing its overhyped patents with promissory notes, and it should be quite obvious what investors need to watch out for when dealing with this ticker.
With that in mind, let the buyer be ware
Recent SBFM News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:05:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 03/05/2024 09:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:03:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:28:39 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/21/2024 01:24:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 04:39:32 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:53:03 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/14/2024 04:18:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/13/2024 05:15:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:04:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:17:56 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:17:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 05:38:24 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2024 01:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:59:51 PM
- Sunshine Biopharma Moves Principal Office to New York City • GlobeNewswire Inc. • 12/04/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:00:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 04:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 05:06:33 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/19/2023 04:10:36 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM